Clinical Trial Results:
A Phase IV, Observer-Blind, Randomized, Parallel Groups, Single-Center, Exploratory Clinical Study to Evaluate the Immunogenicity and Safety of Two 0.25 mL Intramuscular Doses of Agrippal™ S1, Influvac™, and Vaxigrip™ Influenza Vaccines in Healthy Subjects aged 6 to <36 months.
Summary
|
|
EudraCT number |
2004-001952-35 |
Trial protocol |
FI |
Global completion date |
15 Sep 2005
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
Yes
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
17 Feb 2019
|
First version publication date |
17 Feb 2019
|
Other versions |
|
Summary report(s) |
M71P1 results |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.